Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
E.H. Brown, J.R. Lehr, J.P. Smith, and A.W. Frazier. Preparation and characterization of some calcium pyrophosphates. J Agricultural and Food Chemistry. 11:214 (1963).
D.J. McCarty, N.N. Kohn, and J.S. Faires. The significance of calcium pyrophosphate crystals in the synovial fluid of arthritis patients; the “pseudogout” syndrome. Ann Intern Med. 56: 711 (1962).
L.M. Ryan and H.S. Cheung. The role of crystals in osteoarthritis, in: Osteoarthritis, Rheumatic Diseases of America. K.D. Brandt, ed; WB Saunders Co. Philadelphia. 25:257 (1999).
K.P.H. Pritzker. Calcium pyrophosphate crystal arthropathy: a biomineralization disorder. Human Pathology 17:543 (1986).
R.A. Terkeltaub. Pathogenesis and treatment of crystal-inducedinflammation, in: Arthritis and Allied Conditions. A Textbook of Rheumatology. W.J. Koopman, ed; Wlliams and Wilkins. Baltimore. MD 2085 (1997).
W.E. Brown and T.M. Gregory. Calcium pyrophosphate crystal chemistry. Arthritis and Rheum. 19:446 (1976).
L.M. Ryan, I.V. Kurup, B.A. Derfus and V.M. Kushnaryov. ATP-induced chondrocalcinosis. Arthritis Rheum. 35: 1520 (1992).
K.P.H. Pritzker. Calcium pyrophosphate crystal formation and dissolution, in: Calcium Phosphates in Biological and lndustrial systems. Z. Amjad, ed; Chpt. 12: 277 Kuwer Acad. Publ. Dordrecht. Netherlands (1998).
D.J. McCarty, D.W. Palmer, and P.B. Halverson. Clearance of calcium pyrophosphate dihydrate crystals in vivo. I. Studies using 169yb labelledtriclinic crystals. ArthritisRheum. 22:718 (1979).
H.M. Burt and J.K. Jackson. Characterization and membranolytic effects of triclinic calcium pyrophosphate crystals. J Rheum. 14:968 (1987).
P-T. Cheng, K.P.H. Pritzker, M.E. Adams, S.C. Nyburg, and S.A. Omar. Calcium pyrophosphate crystal formation in aqueous solutions. JRheum. 7: 609 (1980).
N.S. Mandel and G.S. Mandel. Calcium pyrophosphate crystal deposition in model systems in: Rheum Disease Clinics of North America 14: 321 (1988).
N. Mandel, and G. Mandel. A model for human calcium pyrophosphate crystal deposition disease. Crystallization kinetics in a gelatin matrix model. Scanning Electron Microscopy IV: 1779 (1984).
K.P.H. Pritzker, P-T. Cheng, M.E. Adams, and S.C. Nyburg. Calcium pyrophosphate dihydrate crystal formation in model hydrogels. J of Rheumatology. 5:469 (1978)
G. Williams and J.D. Sallis. Structure-activity relationship of inhibitors of hydroxyapatite formation. Biochem J. 184: 181 (1979).
W.P. Tew, C. Mahle, J. Benavides, J.E. Howard, and A.L. Lehninger. Synthesis and characterization of phosphocitrate, a potent inhibitor of hydroxyapatite crystal growth. Biochemistty.l9:1983 (1980).
G. Williams and J.D. Sallis. Structural factors influencing the ability of compounds to inhibit hydroxyapatite formation. Calc Tissue Int. 34: 169 (1982).
J.D. Sallis, N.F.G. Parry, J.D. Meehan, H. Kamperman, and M.E. Anderson. Controlling influence of phosphocitrate in vitro and in vivo on calcium oxalate crystal formation and growth. Scanning Microscopy 9: 127 (1995).
A. Wierzbicki, C.S. Sikes, J.D. Sallis, J.D. Madura, E.D. Stevens, and K.L. Martin. Scanning electron microscopy and molecular modeling of inhibition of calcium oxalate monohydrate crystal growth by citrate and phosphocitrate. Calc Tissue Int. 56:297 (1995).
J.D. Sallis, W. Juckes, and M.E. Anderson. Phosphocitrate: Potential to influence deposition of scaling salts and corrosion. In: Mineral Scale Formation and Inhibition (Z. Amjad, ed.). Plenum Press, NY. Chapt.8: 87 (1996).
H.S. Cheung, I.V. Kurup, J.D. Sallis, and L.M. Ryan. Inhibition of calcium pyrophosphate dihydrate crystal formation in articular cartilage vesicles and cartilage by phosphocitrate. J Biol Chem. 271:28082 (1996).
J.D. Sallis, R. Thomson, B. Rees, and R. Shankar. Reduction of infection stones in rats by combination antibiotic and phosphocitrate therapy. J Urol. 140: 1063 (1989).
A. Wierzbicki, J.D. Sallis, E.D. Stevens, M. Smith, and C.S. Sikes. Crystal growth and molecular modeling studies of inhibition of struvite by phosphocitrate. Calc Tissue Int. 61:216 (1997).
J.D. Sallis, R. Shankar. B. Rees, and R. Thomson. Protection of crystal-induced polymorphonuclear leukocyte membranolysis by phosphocitrate. Biochem Med Metab Biol. 41:56 (1989).
D. Nair, R.P. Misra, J.D. Sallis, and H.S. Cheung. Phosphocitrate inhibits a basic calcium phosphate and calcium pyrophosphate dihydrate crystal-induced mitogen-activated protein kinase cascade signal transduction pathway. J Biol Chem. 272: 18920 (1997).
L.M. Ryan and D.J. McCarty. Calcium pyrophosphate crystal deposition disease, pseudogout, and articular chondrocalcinosis, in: Arthritis and Allied Condition. A Textbook of Rheumatology. W.J. Koopman, ed; Williams and Wilkins, Baltimore, Md. 2103 (1997).
J.D. Sallis. Structure/performance relationships of phosphorous and carboxyl containing additives as calcium phosphate crystal growth inhibitors, in: Calcium Phosphates in Biological and Industrial Systems. Z. Amjad, ed; Kluwer Acad. Publ. Dordrecht, Netherlands. 173 (1998).
M. Johnsson, C.F. Richardson, J.D. Sallis, and G.H. Nancollas. Adsorption and mineralization effects of citrate and phosphocitrate on hydroxyapatite. Calc Tissue Int 49: 134 (1991).
V.K. Sharma, M. Johnsson, J.D. Sallis, and G.H. Nancollas. Influence of citrate and phosphocitrate on the crystallization of octacalcium phosphate. Langmuir. 8:676 (1992).
A. Wierzbicki and H.S. Cheung. Molecular modeling of inhibition of crystals of calcium pyrophosphate by phosphocitrate. Theochem. 454:287 (1998).
N.S. Mandel. The crystal structure of calcium pyrophosphate dihydrate. Acta Ctystallographica. B31:1730 (1973).
G.S. Mandel, K.M. Renne, A.M. Kolbach, A.M. Kaplan, J.D. Miller, and N.S. Mandel. Calcium pyrophosphate crystal deposition disease: preparation and characterization of crystals. J of Crystal Growth. 87: 453 (1988).
T. Shinozaki, Y. Xu, T.F. Cruz, and K.P.H. Pritzker. Calcium pyrophosphate dihydrate (CPPD) crystal dissolution by alkaline phosphatase: interaction of alkaline phosphatase on CPPD crystals. J Rheum. 22:117 (1995).
K.D. Altria, M. Wallberg, and D. Westerlund. Separation of a range of cations by nonaqueous capillary electrophoresis using indirect and direct detection. J Chromatogr. B 714:99 (1998).
C.H. Fiske and J. Subbarow. Colorimetric detection of phosphorus. J Biol Chem. 66:375 (1925).
P-T. Cheng and K.P.H. Pritzker. The effect of calcium and magnesium ions on calcium pyrophosphate crystal formation in aqueous solutions. J Rheum. 8: 772 (1981).
M. Doherty and P.A. Dieppe. Double blind, placebo controlled trial of magnesium carbonate in chronic calcium pyrophosphate arthropathy. Ann Rheum. Dis. 42 (suppl): 106 (1983).
T. Shinozaki and K.P.H. Pritzker. Polyamines enhance calcium pyrophosphate dihydrate crystal dissolution. J Rheumatol 22: 1907 (1995).
H.E. Krug, M.L. Mahowald, P.B. Halverson, J.D. Sallis, and H.S. Cheung. Phosphocitrate prevents disease progression in murine progressive ankylosis. Arthritis and Rheumatism. 36: 1603 (1993).
A.L. Lehninger. The possible role of mitochondria and phosphocitrate in biological calcification, in: Biomineralization and Biological Metal Accumulation. P. Westbroek and E. W. de Jong, eds., D. Reidel Publishing Co., NY. 107 (1983).
G. Williams and J.D. Sallis. The sources of phosphocitrate and its role as an inhibitor of calcium phosphate and calcium oxalate crystallization, in: Urolithiasis. L.H. Smith and W.R. Finlayson, ed., Penum Press. NY. 569 (1981).
J.D. Meehan and J.D. Sallis. Kidney selective prodrugs of phosphocitrate: Synthesis and in vivo hydrolysis of γ-glutamyl derivatives of phosphocitrate and their in vivo influence on nephrocalcinosis. Pharm Sci. 1: 289 (1995).
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2002 Kluwer Academic Publishers
About this chapter
Cite this chapter
Sallis, J.D., Wierzbicki, A., Cheung, H.S. (2002). Calcium Pyrophosphate Crystal Salt forms and the Influence of Phosphocitrate. In: Amjad, Z. (eds) Advances in Crystal Growth Inhibition Technologies. Springer, Boston, MA. https://doi.org/10.1007/0-306-46924-3_5
Download citation
DOI: https://doi.org/10.1007/0-306-46924-3_5
Publisher Name: Springer, Boston, MA
Print ISBN: 978-0-306-46499-7
Online ISBN: 978-0-306-46924-4
eBook Packages: Springer Book Archive